Anderson Hoagland & Co Has Decreased Henry Schein (HSIC) Stake by $584,016 as Share Price Declined; As Medidata Solutions (MDSO) Stock Price Declined, Ranger Investment Management LP Has Trimmed Position

May 16, 2018 - By Kurt Siggers

Henry Schein, Inc. (NASDAQ:HSIC) Logo

Ranger Investment Management Lp decreased its stake in Medidata Solutions Inc. (MDSO) by 4.62% based on its latest 2017Q4 regulatory filing with the SEC. Ranger Investment Management Lp sold 19,241 shares as the company’s stock declined 3.23% with the market. The institutional investor held 397,446 shares of the technology company at the end of 2017Q4, valued at $25.19 million, down from 416,687 at the end of the previous reported quarter. Ranger Investment Management Lp who had been investing in Medidata Solutions Inc. for a number of months, seems to be less bullish one the $4.48 billion market cap company. It closed at $75.65 lastly. It is down 13.38% since May 16, 2017 and is uptrending. It has outperformed by 1.83% the S&P500.




Anderson Hoagland & Co decreased its stake in Henry Schein Inc (HSIC) by 43.65% based on its latest 2017Q4 regulatory filing with the SEC. Anderson Hoagland & Co sold 8,464 shares as the company’s stock declined 8.35% with the market. The institutional investor held 10,926 shares of the health care company at the end of 2017Q4, valued at $764,000, down from 19,390 at the end of the previous reported quarter. Anderson Hoagland & Co who had been investing in Henry Schein Inc for a number of months, seems to be less bullish one the $11.15 billion market cap company. The stock decreased 0.07% or $0.05 during the last trading session, reaching $72.4. About 806,272 shares traded. Henry Schein, Inc. (NASDAQ:HSIC) has declined 24.00% since May 16, 2017 and is downtrending. It has underperformed by 35.55% the S&P500.

Analysts await Henry Schein, Inc. (NASDAQ:HSIC) to report earnings on August, 14. They expect $1.01 earnings per share, up 14.77% or $0.13 from last year’s $0.88 per share. HSIC’s profit will be $155.56 million for 17.92 P/E if the $1.01 EPS becomes a reality. After $0.95 actual earnings per share reported by Henry Schein, Inc. for the previous quarter, Wall Street now forecasts 6.32% EPS growth.

More recent Henry Schein, Inc. (NASDAQ:HSIC) news were published by: Streetinsider.com which released: “Pre-Open Movers 04/23: (MDR) (VVC) (HSIC) Higher; (AKRX) (CBI) (AA) Lower (more…)” on April 23, 2018. Also Globenewswire.com published the news titled: “Kaskela Law LLC: Shareholder Class Action Filed Against Henry Schein, Inc – HSIC” on May 04, 2018. Seekingalpha.com‘s news article titled: “Henry Schein (HSIC) Q1 2018 Results – Earnings Call Transcript” with publication date: May 08, 2018 was also an interesting one.

Investors sentiment decreased to 0.83 in Q4 2017. Its down 6.32, from 7.15 in 2017Q3. It dived, as 72 investors sold HSIC shares while 170 reduced holdings. 62 funds opened positions while 139 raised stakes. 146.17 million shares or 47.74% less from 279.70 million shares in 2017Q3 were reported. Profund Advsrs Ltd Liability reported 0.04% in Henry Schein, Inc. (NASDAQ:HSIC). Ameriprise Financial owns 168,842 shares or 0.01% of their US portfolio. First Manhattan holds 1,090 shares or 0% of its portfolio. Leavell Invest Management reported 0.24% stake. Moreover, Bell Bancshares has 0.06% invested in Henry Schein, Inc. (NASDAQ:HSIC). Jane Street Group Ltd Llc has invested 0.01% in Henry Schein, Inc. (NASDAQ:HSIC). Oregon Pub Employees Retirement Fund stated it has 0.05% of its portfolio in Henry Schein, Inc. (NASDAQ:HSIC). Daiwa Securities Gp Inc holds 0.02% in Henry Schein, Inc. (NASDAQ:HSIC) or 42,911 shares. Connor Clark Lunn Invest Mngmt Ltd has 53,350 shares. First Interstate Bancshares holds 110 shares or 0% of its portfolio. Avenir Corporation stated it has 306,971 shares or 1.98% of all its holdings. Acadian Asset Mgmt Ltd Company accumulated 2,968 shares. Williams Jones Assocs Ltd stated it has 0.06% of its portfolio in Henry Schein, Inc. (NASDAQ:HSIC). Greenleaf reported 312 shares or 0% of all its holdings. The Pennsylvania-based Glenmede Company Na has invested 0% in Henry Schein, Inc. (NASDAQ:HSIC).

Among 23 analysts covering Henry Schein Inc. (NASDAQ:HSIC), 12 have Buy rating, 1 Sell and 10 Hold. Therefore 52% are positive. Henry Schein Inc. had 56 analyst reports since July 31, 2015 according to SRatingsIntel. Gabelli upgraded the stock to “Buy” rating in Tuesday, January 10 report. Stifel Nicolaus maintained the stock with “Hold” rating in Wednesday, July 5 report. The firm earned “Hold” rating on Tuesday, November 28 by Credit Suisse. The stock has “Neutral” rating by Robert W. Baird on Friday, October 14. The firm earned “Hold” rating on Wednesday, September 27 by Jefferies. The company was maintained on Tuesday, November 7 by Robert W. Baird. As per Tuesday, August 22, the company rating was maintained by Jefferies. The stock of Henry Schein, Inc. (NASDAQ:HSIC) has “Hold” rating given on Tuesday, April 24 by Goldman Sachs. As per Thursday, October 6, the company rating was initiated by UBS. On Friday, September 15 the stock rating was maintained by UBS with “Buy”.

More recent Medidata Solutions, Inc. (NASDAQ:MDSO) news were published by: Seekingalpha.com which released: “J&J cost cutting plan may pressure suppliers – Bloomberg” on April 17, 2018. Also Seekingalpha.com published the news titled: “Medidata Solutions’ (MDSO) CEO Tarek Sherif on Q1 2018 Results – Earnings Call” on April 19, 2018. Globenewswire.com‘s news article titled: “Report: Exploring Fundamental Drivers Behind Gartner, F5 Networks, Medidata Solutions, Evertec, Ring Energy, and …” with publication date: May 15, 2018 was also an interesting one.

Investors sentiment increased to 1.71 in Q4 2017. Its up 0.48, from 1.23 in 2017Q3. It improved, as 22 investors sold MDSO shares while 61 reduced holdings. 49 funds opened positions while 93 raised stakes. 61.06 million shares or 2.97% more from 59.30 million shares in 2017Q3 were reported. Arcadia Investment Mngmt Mi reported 63,803 shares. Amer Group Incorporated reported 157,725 shares. 685,772 are held by Royal Fincl Bank Of Canada. Asset Mngmt One reported 1,948 shares. Tiaa Cref Invest Mngmt Limited Com owns 159,860 shares. Moreover, Frontier Management Ltd has 0.03% invested in Medidata Solutions, Inc. (NASDAQ:MDSO). State Treasurer State Of Michigan invested 0.01% in Medidata Solutions, Inc. (NASDAQ:MDSO). Blackrock holds 0.02% or 6.63 million shares. Comm Retail Bank stated it has 0.01% in Medidata Solutions, Inc. (NASDAQ:MDSO). Voya Inv Management Ltd Llc stated it has 986,391 shares or 0.13% of all its holdings. Fred Alger Inc holds 0.18% or 627,943 shares. Us Bancorp De holds 8,698 shares or 0% of its portfolio. Jpmorgan Chase & invested in 1.32M shares or 0.02% of the stock. Driehaus Cap Mgmt holds 15,355 shares or 0.04% of its portfolio. 21,526 are owned by Peak6 Investments Lp.

Ranger Investment Management Lp, which manages about $2.16 billion and $1.36B US Long portfolio, upped its stake in Ceva Inc (NASDAQ:CEVA) by 42,812 shares to 602,256 shares, valued at $27.79 million in 2017Q4, according to the filing. It also increased its holding in Pegasystems Inc. (NASDAQ:PEGA) by 204,711 shares in the quarter, for a total of 965,692 shares, and has risen its stake in Quaker Chemical (NYSE:KWR).

Among 17 analysts covering Medidata Solutions Inc. (NASDAQ:MDSO), 14 have Buy rating, 0 Sell and 3 Hold. Therefore 82% are positive. Medidata Solutions Inc. had 45 analyst reports since July 22, 2015 according to SRatingsIntel. On Sunday, October 22 the stock rating was maintained by KeyBanc Capital Markets with “Buy”. Topeka Capital Markets maintained Medidata Solutions, Inc. (NASDAQ:MDSO) rating on Thursday, February 11. Topeka Capital Markets has “Buy” rating and $42 target. The stock of Medidata Solutions, Inc. (NASDAQ:MDSO) has “Underperform” rating given on Tuesday, April 26 by Jefferies. The stock of Medidata Solutions, Inc. (NASDAQ:MDSO) has “Buy” rating given on Thursday, February 8 by Piper Jaffray. The rating was upgraded by Dougherty to “Buy” on Monday, November 13. The stock of Medidata Solutions, Inc. (NASDAQ:MDSO) earned “Buy” rating by SunTrust on Friday, October 27. As per Thursday, October 26, the company rating was maintained by Piper Jaffray. The firm has “Buy” rating given on Monday, January 22 by SunTrust. The rating was downgraded by Wells Fargo to “Market Perform” on Thursday, July 21. KeyBanc Capital Markets maintained the stock with “Buy” rating in Sunday, September 17 report.

Analysts await Medidata Solutions, Inc. (NASDAQ:MDSO) to report earnings on July, 17. They expect $0.22 earnings per share, up 22.22% or $0.04 from last year’s $0.18 per share. MDSO’s profit will be $13.02M for 85.97 P/E if the $0.22 EPS becomes a reality. After $0.24 actual earnings per share reported by Medidata Solutions, Inc. for the previous quarter, Wall Street now forecasts -8.33% negative EPS growth.

Since December 19, 2017, it had 0 insider buys, and 10 sales for $5.59 million activity. Sherif Tarek sold $1.89M worth of stock or 26,836 shares. Shares for $1.88 million were sold by de Vries Glen Michael. Shares for $728,170 were sold by Otner Michael I. on Wednesday, April 25.

Henry Schein, Inc. (NASDAQ:HSIC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: